Chen Hongxiu, Zhou Wu, Zhang Jiali, Lv Jieying, Su Xiaotian, Wang Qiuzhou, Wu Zhoupeng, Zhang Xiaoxia, Hu Xiuying
Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
West China School of Nursing, Sichuan University, Chengdu, China.
Breast Cancer. 2025 Jul 24. doi: 10.1007/s12282-025-01748-w.
Venous thromboembolism (VTE) is a serious complication in breast cancer patients. However, limited attention has been given to its clinical characteristics and progression, particularly in Asian populations. Therefore, this study aimed to comprehensively investigate the clinical topography and progression of VTE in breast cancer patients using ultrasound in China.
This prospective study was conducted at a 4500-bed tertiary hospital from August 2021 to September 2022. VTE was assessed routinely before discharge and upon self-reported symptoms. Patients without VTE during hospitalization were followed up at the 1, 3, and 6 months post-operation. Patients with VTE received weekly ultrasounds to monitor their progression. Data on clinical features, progression, and VTE-related healthcare burden were collected.
The cumulative incidence of VTE within six months was 19.96%, comprising lower-extremity superficial vein thrombosis (LE-SVT), lower-extremity deep vein thrombosis (LE-DVT), central venous catheter-related thrombosis (CRT), upper-extremity vein thrombosis, and pulmonary embolism (PE). VTE occurred as early as the first postoperative day, with 88.8% of cases developing during hospitalization, primarily LE-SVT and LE-DVT. CRT became predominant one month post-surgery. Early common symptoms included pain or tenderness along the puncture site, fullness pain/cramping pain/aching pain during activity. By the end of follow-up, most thrombi resolved, with minimal progression. VTE led to an additional 236 outpatient/emergency visits, three hospitalizations, and ¥148,211 costs.
VTE incidence in breast cancer patients was high post-surgery, with distinct patterns of occurrence and progression. Early symptoms were often mild, nonspecific, and transient. While most thrombi resolve, VTE imposes a heavy medical burden and requires medical attention.
静脉血栓栓塞症(VTE)是乳腺癌患者的一种严重并发症。然而,对其临床特征和进展的关注有限,尤其是在亚洲人群中。因此,本研究旨在利用超声全面调查中国乳腺癌患者VTE的临床分布及进展情况。
本前瞻性研究于2021年8月至2022年9月在一家拥有4500张床位的三级医院进行。在出院前和患者自述有症状时常规评估VTE。住院期间无VTE的患者在术后1、3和6个月进行随访。VTE患者每周接受超声检查以监测其进展情况。收集有关临床特征、进展情况以及与VTE相关的医疗负担的数据。
六个月内VTE的累积发生率为19.96%,包括下肢浅静脉血栓形成(LE-SVT)、下肢深静脉血栓形成(LE-DVT)、中心静脉导管相关血栓形成(CRT)、上肢静脉血栓形成和肺栓塞(PE)。VTE最早在术后第一天出现,88.8%的病例在住院期间发生,主要是LE-SVT和LE-DVT。CRT在术后一个月成为主要类型。早期常见症状包括穿刺部位疼痛或压痛、活动时胀痛/痉挛性疼痛/酸痛。到随访结束时,大多数血栓溶解,进展极小。VTE导致额外236次门诊/急诊就诊、三次住院以及148,211元的费用。
乳腺癌患者术后VTE发生率较高,发生和进展模式各异。早期症状通常较轻、不具特异性且短暂。虽然大多数血栓会溶解,但VTE带来沉重的医疗负担,需要引起医疗关注。